Underactive Bladder, Urinary Retention
Conditions
Keywords
pudendal nerve mapping
Brief summary
This study is to map the pudendal nerve. In this study the researchers will examine subjects who are already receiving an implanted stimulator at their pudendal nerve as part of their normal clinical care.
Detailed description
The pudendal nerve goes to the urethra, anus, and other areas of the pelvic floor. Electrical stimulation of this nerve can help with bladder problems and pelvic pain. Researchers do not understand how the nerve anatomy is different between people. Successfully mapping the pudendal nerve may help improve the medical care for future patients with bladder problems, pelvic pain, bowel problems, and sexual problems.
Interventions
Participants in study received neurostimulator at their pudendal nerve as part of their normal clinical care. This neurostimulator was used to map the nerve.
Sponsors
Study design
Eligibility
Inclusion criteria
* Clinically referred as having bladder problems that have not responded to conservative treatment. Normal clinical care includes referral to implant of Medtronic Interstim neurostimulator at the pudendal nerve. Fully eligible to receive an Interstim implant. * Adult (18 or older), capable of providing own informed consent and communicating clearly with research team * Capable of speaking, reading, and understanding English, as all study questionnaires are standardized assessments only available in English * Capable of attending all experimental sessions (Visit 1: pre-stage-1 imaging, Visit 2: stage-1 surgery, Visit 3: CT after stage-2 surgery, Visit 3: cystometrogram test) Exclusion * Implanted materials that prohibit magnetic imaging * Any medical problems that prevent an individual from laying flat in an MRI or CT scanner, are are claustrophobic. * Areflexive or atonic bladder * Pregnant or planning to become pregnant. If a woman of child-bearing potential wishes to participate in this study, they will be pre-screened with a test to detect pregnancy. * Diagnosed neurogenic bladder, pudendal nerve damage, lower motor dysfunction, or other conditions that would affect the neural circuits involved in micturition. * Unwilling to allow de-identified data to be stored for future use or shared with other researchers.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Number of Participants With Evoked Bladder Contractions of at Least 20 Centimeters of Water (cmH2O) During the Stage-4 Test | Visit 4, approximately 10 weeks after consent | The primary outcome measure in this study was an evoked bladder contraction of at least 20 centimeters of water (cmH2O) during the cystometrogram. These bladder contractions were evoked by applying nerve stimulation to the pudendal nerve through testing of the participant's implanted stimulator. Measure reflects number of participants who experienced an evoked bladder contraction of at least 20 centimeters of water during nerve stimulation. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Selectivity Index (SI) for Selective Stimulation of Pudendal Nerve Branches for Participant Stimulation | Visit 2: Stage-1 (approximately 3 weeks after consent) | Selectivity refers to the degree in which a nerve could be stimulated without stimulating other nerves. SI was calculated for each sensor recording from locations innervated by distal pudendal nerve branches during the visit-2 implant procedure. This includes pressure sensors in the urethra innervated by the perineal nerve and anal electromyography (EMG) innervated by the ischeal rectal nerve. The SI calculation used here is on a scale of 0 to 1, with 0 indicating no response at all from the nerve. The closer the number is to 1, the more selective the nerve stimulated. |
| Selectivity Index (SI) for Selective Stimulation of Pudendal Nerve Branches for Simulated Model Stimulation | Approximately one year and four months after consent | Selectivity is the degree to which part of a nerve could be stimulated without stimulating other nerve parts. For each participant who had successful MRI and CT images, a computational model was created to simulate electrical stimulation of axons distributed in two primary pudendal fascicles: perineal and rectal. The SI of stimulation does not indicate a positive or negative result in this outcome; rather, it shows the relative potential for activating just a single nerve fascicle. The negative/positive designation identifies the regional nerve activation, with -1 representing only perineal fascicle activation, +1 representing only rectal activation, and 0 indicating equal activation of both fascicles. |
| Measurement of Effect of Pudendal Nerve Stimulation on Urethral Leak Point Pressure During the Stage-4 Test | Visit 4, approximately 10 weeks after consent | A secondary outcome measure was a goal to examine the effect of selective pudendal nerve stimulation on urethral leak point pressure during the cystometrogram. |
Countries
United States
Participant flow
Participants by arm
| Arm | Count |
|---|---|
| Study Participants Study participants received an implanted neurostimulator at their pudendal nerve and consented to participate in study activities. | 22 |
| Total | 22 |
Withdrawals & dropouts
| Period | Reason | FG000 |
|---|---|---|
| Overall Study | Participants did not receive implant at all | 4 |
| Overall Study | Participants did not retain implant for entire trial | 3 |
| Overall Study | Withdrawal by Subject | 1 |
Baseline characteristics
| Characteristic | Study Participants |
|---|---|
| Age, Continuous | 54.37 years STANDARD_DEVIATION 13.15 |
| Ethnicity (NIH/OMB) Hispanic or Latino | 1 Participants |
| Ethnicity (NIH/OMB) Not Hispanic or Latino | 20 Participants |
| Ethnicity (NIH/OMB) Unknown or Not Reported | 1 Participants |
| Race (NIH/OMB) American Indian or Alaska Native | 0 Participants |
| Race (NIH/OMB) Asian | 0 Participants |
| Race (NIH/OMB) Black or African American | 1 Participants |
| Race (NIH/OMB) More than one race | 0 Participants |
| Race (NIH/OMB) Native Hawaiian or Other Pacific Islander | 0 Participants |
| Race (NIH/OMB) Unknown or Not Reported | 0 Participants |
| Race (NIH/OMB) White | 21 Participants |
| Region of Enrollment United States | 22 Participants |
| Sex: Female, Male Female | 18 Participants |
| Sex: Female, Male Male | 4 Participants |
Adverse events
| Event type | EG000 affected / at risk |
|---|---|
| deaths Total, all-cause mortality | 0 / 22 |
| other Total, other adverse events | 0 / 22 |
| serious Total, serious adverse events | 0 / 22 |
Outcome results
Number of Participants With Evoked Bladder Contractions of at Least 20 Centimeters of Water (cmH2O) During the Stage-4 Test
The primary outcome measure in this study was an evoked bladder contraction of at least 20 centimeters of water (cmH2O) during the cystometrogram. These bladder contractions were evoked by applying nerve stimulation to the pudendal nerve through testing of the participant's implanted stimulator. Measure reflects number of participants who experienced an evoked bladder contraction of at least 20 centimeters of water during nerve stimulation.
Time frame: Visit 4, approximately 10 weeks after consent
Population: Due to scheduling conflicts and participant attrition, only 10 participants completed this part of the study. All were women.
| Arm | Measure | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|
| Participants Undergoing Cystometrogram | Number of Participants With Evoked Bladder Contractions of at Least 20 Centimeters of Water (cmH2O) During the Stage-4 Test | 0 Participants |
Measurement of Effect of Pudendal Nerve Stimulation on Urethral Leak Point Pressure During the Stage-4 Test
A secondary outcome measure was a goal to examine the effect of selective pudendal nerve stimulation on urethral leak point pressure during the cystometrogram.
Time frame: Visit 4, approximately 10 weeks after consent
Population: Selective pudendal nerve stimulation was not performed during the cystometrogram sessions due to time limitations within experimental sessions, so there is no data available. Selectivity could not be accomplished as it was described in the protocol for this nerve bundle.
Selectivity Index (SI) for Selective Stimulation of Pudendal Nerve Branches for Participant Stimulation
Selectivity refers to the degree in which a nerve could be stimulated without stimulating other nerves. SI was calculated for each sensor recording from locations innervated by distal pudendal nerve branches during the visit-2 implant procedure. This includes pressure sensors in the urethra innervated by the perineal nerve and anal electromyography (EMG) innervated by the ischeal rectal nerve. The SI calculation used here is on a scale of 0 to 1, with 0 indicating no response at all from the nerve. The closer the number is to 1, the more selective the nerve stimulated.
Time frame: Visit 2: Stage-1 (approximately 3 weeks after consent)
Population: Data was collected from 16 participants who received the implant.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Participants Undergoing Cystometrogram | Selectivity Index (SI) for Selective Stimulation of Pudendal Nerve Branches for Participant Stimulation | Perineal nerve | 0.57 index | Standard Deviation 0.29 |
| Participants Undergoing Cystometrogram | Selectivity Index (SI) for Selective Stimulation of Pudendal Nerve Branches for Participant Stimulation | Rectal nerve | 0.90 index | Standard Deviation 0.22 |
Selectivity Index (SI) for Selective Stimulation of Pudendal Nerve Branches for Simulated Model Stimulation
Selectivity is the degree to which part of a nerve could be stimulated without stimulating other nerve parts. For each participant who had successful MRI and CT images, a computational model was created to simulate electrical stimulation of axons distributed in two primary pudendal fascicles: perineal and rectal. The SI of stimulation does not indicate a positive or negative result in this outcome; rather, it shows the relative potential for activating just a single nerve fascicle. The negative/positive designation identifies the regional nerve activation, with -1 representing only perineal fascicle activation, +1 representing only rectal activation, and 0 indicating equal activation of both fascicles.
Time frame: Approximately one year and four months after consent
Population: Computational models were created for 10 participants who received the implant. The model data was segregated into three groups: participants with selectivity indices positive (\>0) for all four contacts (rectal only), negative (\<0) for all four contacts (perineal only), and mixed (both \>0 and \<0). Each group has the same potential range for SI values: -1 to +1. Values in the Outcome Measure Data Table are calculations across all lead contacts and participants per group.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Participants Undergoing Cystometrogram | Selectivity Index (SI) for Selective Stimulation of Pudendal Nerve Branches for Simulated Model Stimulation | Rectal dominant | 0.577 index | Standard Deviation 0.193 |
| Participants Undergoing Cystometrogram | Selectivity Index (SI) for Selective Stimulation of Pudendal Nerve Branches for Simulated Model Stimulation | Perineal dominant | -0.533 index | Standard Deviation 0.284 |
| Participants Undergoing Cystometrogram | Selectivity Index (SI) for Selective Stimulation of Pudendal Nerve Branches for Simulated Model Stimulation | Mixed | 0.288 index | Standard Deviation 0.666 |